Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Progyny Inc (PGNY)

  • Business News
  • Nov. 13, 2025, 17:33 UTC
  • 9
  • 1 comments

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

Market reaction Comment Full text

Legend Biotech (LEGN)

  • Business News
  • Nov. 13, 2025, 17:08 UTC
  • 9
  • 1 comments

Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Market reaction Comment Full text

Vicarious Surgical Inc (RBOT)

  • Business News
  • Nov. 13, 2025, 16:56 UTC
  • 8
  • 0 comments

Vicarious Surgical Inc. - Opening the Curtain on How We Build: A Brief Message from our CEO

Market reaction Comment Full text

Mersana Therapeutics (MRSN)

  • Business News
  • Nov. 13, 2025, 16:35 UTC
  • 15
  • 1 comments

Shareholder Alert: The Ademi Firm investigates whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

Market reaction Comment Full text

Pfizer Inc (PFE)

  • Business News
  • Nov. 13, 2025, 16:27 UTC
  • 11
  • 0 comments

Pfizer Inc. - Pfizer Completes Acquisition of Metsera

Market reaction Comment Full text

Pfizer Inc (PFE)

  • Business News
  • Nov. 13, 2025, 16:26 UTC
  • 17
  • 1 comments

Pfizer Completes Acquisition of Metsera

Market reaction Comment Full text

National Research (NRC)

  • Business News
  • Nov. 13, 2025, 16:17 UTC
  • 9
  • 0 comments

The latest from NRC Health | How Nemours Childrens Health delivered on patient experience, NRC Healths new partners, and so much more!

Market reaction Comment Full text

Kura Oncology Inc (KURA)

  • Business News
  • Nov. 13, 2025, 15:51 UTC
  • 17
  • 1 comments

Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

Market reaction Comment Full text

Masimo Corporation (MASI)

  • Business News
  • Nov. 13, 2025, 14:49 UTC
  • 16
  • 1 comments

Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction

Market reaction Comment Full text

BIOHARVEST SCIENCES INC. (CNVCF)

  • Business News
  • Nov. 13, 2025, 14:42 UTC
  • 16
  • 1 comments

BIOHARVEST SCIENCES ANNOUNCES CLOSING OF $19.9 MILLION UPSIZED PUBLIC OFFERING OF COMMON STOCK AND EXERCISE OF UNDERWRITER’S OPTION TO PURCHASE ADDITIONAL SHARES

Market reaction Comment Full text
  • Previous
  • 654
  • 655
  • 656
  • 657
  • 658
  • Next

Search

News categories

  • Technical Exchange News(10960)
  • Event(2424)
  • SEC News(192986)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125657)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin